Metabolic syndrome in menopause: Physiopathological, clinic and therapeutic aspects for cardiovascular prevention;Sindrome metabolica in menopausa: Aspetti fisiopatologici, clinici e terapeutici in ordine alla prevenzione cardiovascolare

Recenti Progressi in Medicina

Volumn 98, Issue 3, 2007, Pages 185-191

  Sinagra, Domenico ^a,b   Conti, Michela ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Arterial hypertension; Cardiovascular prevention; Cardiovascular risk; Diabetes mellitus; HDL cholesterol; Hyperinsulinemia; Insulin resistance; Menopause; Metabolic syndrome; Obesity; Physical activity; Rimonabant

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HUMAN; MENOPAUSE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; QUALITY OF LIFE; REVIEW;

ADULT; AGE FACTORS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; EXERCISE; FEMALE; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; QUALITY OF LIFE; RISK FACTORS; SEX FACTORS; WEIGHT LOSS; WORLD HEALTH ORGANIZATION;

EID: 34247351976     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Carr BR, Bradshaw KD. Malattie dell'ovaio e dell'apparato riproduttivo femminile. In: Harrison TR. Principi di medicina interna. Ed ital Milano: McGraw Hill 1999: 2398-9.
2. Torng PL, et al. Effect of menopause on intraindividual changes in serum lipids, blood pressure, and body weight. The Chin-Shan Community Cardiovascular Cohort Study. Atherosclerosis 2002; 161: 409-15.
3. Barrett-Connor E, et al. Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med 2004; 164: 934-42.
4. Murabito JM, et al. Women and cardiovascular disease: contributions from the Framingham Heart Study. JAMA 1995; 50: 35.
5. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003; 108: 1541-5.
6. Ford ES., Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
7. Isomaa B, Lahti K, Almgren P, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9.
8. Wilson PWF, Grundy SM. The metabolic syndrome: Part 1. Circulation 2003; 108: 1422-5.
9. Eyre H, Kahn R, Robertson RM (for ACS/ADA/AHA Collaborative Writing Committee). Preventing cancer, cardiovascular disease ansd diabetes. A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 2004; 109: 3244-55.
10. Giorda C B. Nuovo inquadramento della sindrome metabolica. II dibattito in corso e le ricadute in medicina generale.Media 2005; 5: 219-25.
11. Reilly MP,Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003; 108: 1546-51.
12. Yu YH, Ginsberg HN. Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue. Circ Res 2005; 96: 1042-52.
13. Hasegawa G, et al. Increased serum resistin levels in patients with tipe 2 diabetes are not linked with markers of insulin resistance and adiposity. Acta Diabetol 2005; 42: 104-9.
14. Farvid MS, et al. Association of adiponectin and resistin with adipose tissue compartiments, insulin resistance and dyslipidaemia. Diabetes Obes Metab 2005; 7: 406-13.
15. Giannopoulou I, et al. Effects of diet and/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes. Metabolism 2005; 54: 866-75.
16. Haffner SM, Mykkanen L, Festa A, et al. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary hearth disease during the prediabetic state. Circulation 2000; 101: 975-80.
17. Guidelines Committee. European Society of Hypertension-European Society of Cardiology. Guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-53.
18. Van Zwieten P A, Mancia G. The metabolic syndrome. A therapeutic challenge. European Society of Hypertension 2005: 24.
19. Ozbey N, Sencer E, Molvalilar S, Orhan Y. Body fat distribution and cardiovascular disease risk factors pre- and postmenopausal obese women with similar BMI. Endocr J 2002; 49: 503-9.
20. Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the renin- angiotensin system. Drugs 2004; 64: 2537-65.